Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-Yu Niu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Experimental Hematology & Oncology|January 14, 2014
Novel agents and strategies for overcoming EGFR TKIs resistanceFei-Yu Niu, Yi-Long Wu
Oncotargets and Therapy|May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibFei-Yu Niu, Yi-Long Wu
Translational Lung Cancer Research|March 26, 2015
Clinical trials for lung cancer in ChinaFei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, et al.
Cancer|September 3, 2015
Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationLan-Ying Gou, Fei-Yu Niu, Yi-Long Wu, et al.
BMC Cancer|October 16, 2015
Multiple primary malignancies involving lung cancerFeng Li, Wen-Zhao Zhong, Fei-Yu Niu, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinomaFei-Yu Niu, Chuan Jin, Lei Ma, et al.
Cell Death & Disease|February 9, 2022
Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loopYing-Ying Liang, Fei-Yu Niu, An-An Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancerAnna Li, Fei-Yu Niu, Jie-Fei Han, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2014
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitorZhu Zeng, Hong-hong Yan, Xu-chao Zhang, et al.
Hepatology International|August 10, 2022
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinomaChuan Jin, Jian-Sen Zhao, Xu-Qi Huang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Experimental Hematology & Oncology|January 14, 2014
Novel agents and strategies for overcoming EGFR TKIs resistanceFei-Yu Niu, Yi-Long Wu
Oncotargets and Therapy|May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibFei-Yu Niu, Yi-Long Wu
Translational Lung Cancer Research|March 26, 2015
Clinical trials for lung cancer in ChinaFei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, et al.
Cancer|September 3, 2015
Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationLan-Ying Gou, Fei-Yu Niu, Yi-Long Wu, et al.
BMC Cancer|October 16, 2015
Multiple primary malignancies involving lung cancerFeng Li, Wen-Zhao Zhong, Fei-Yu Niu, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinomaFei-Yu Niu, Chuan Jin, Lei Ma, et al.
Cell Death & Disease|February 9, 2022
Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loopYing-Ying Liang, Fei-Yu Niu, An-An Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancerAnna Li, Fei-Yu Niu, Jie-Fei Han, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2014
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitorZhu Zeng, Hong-hong Yan, Xu-chao Zhang, et al.
Hepatology International|August 10, 2022
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinomaChuan Jin, Jian-Sen Zhao, Xu-Qi Huang, et al.
Pageof 2